Emicizumab 60mg/0.4ml solution for injection vials
NHS hospitals in England used £138,681,695 of indicative cost of Emicizumab 60mg/0.4ml solution for injection vials in the 12 months to April 2026, about 0.5% of all hospital medicines spend. That is up 4.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Emicizumab 60mg/0.4ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Emicizumab 60mg/0.4ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £26,587,622 |
| Manchester University Nhs Ft | £21,148,367 |
| Univ Hpls Bristol Nhs Foundation Trust | £16,023,100 |
| Oxford University Hospitals Nhs Ft | £12,337,352 |
| Royal Free London Nhs Foundation Trust | £10,443,757 |
| Sheffield Teaching Hospitals Nhs Trust | £7,183,102 |
| Nottingham University Hospitals Trust | £6,743,518 |
| Leeds Teaching Hpls Nhs Trust | £5,796,720 |
| Aintree University Hospital Nhs Ft | £4,820,939 |
| University Hpls Of Leicester Nhs Trust | £4,777,463 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.